Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nephros (NEPH) Non-Current Deffered Revenue (2016 - 2017)

Nephros (NEPH) has 7 years of Non-Current Deffered Revenue data on record, last reported at $208000.0 in Q4 2017.

  • For Q4 2017, Non-Current Deffered Revenue fell 25.18% year-over-year to $208000.0; the TTM value through Dec 2017 reached $208000.0, down 25.18%, while the annual FY2017 figure was $208000.0, 25.18% down from the prior year.
  • Non-Current Deffered Revenue reached $208000.0 in Q4 2017 per NEPH's latest filing, down from $225000.0 in the prior quarter.
  • Across five years, Non-Current Deffered Revenue topped out at $531000.0 in Q1 2013 and bottomed at $176000.0 in Q3 2013.
  • Average Non-Current Deffered Revenue over 5 years is $333833.3, with a median of $338500.0 recorded in 2015.
  • Peak YoY movement for Non-Current Deffered Revenue: tumbled 80.02% in 2013, then surged 146.59% in 2014.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $176000.0 in 2013, then soared by 136.93% to $417000.0 in 2014, then dropped by 16.79% to $347000.0 in 2015, then decreased by 19.88% to $278000.0 in 2016, then decreased by 25.18% to $208000.0 in 2017.
  • Per Business Quant database, its latest 3 readings for Non-Current Deffered Revenue were $208000.0 in Q4 2017, $225000.0 in Q3 2017, and $243000.0 in Q2 2017.